YIPF6 inhibitors are chemical compounds that specifically target and inhibit the activity of YIPF6, a member of the YIP (Ypt-interacting protein) family. YIPF6 is a transmembrane protein that plays a significant role in intracellular trafficking, particularly in the transport of vesicles between the Golgi apparatus and other cellular compartments. The YIP family, including YIPF6, is involved in regulating the function and localization of Rab GTPases, which are key regulators of vesicular transport processes. YIPF6 is believed to be integral in maintaining the proper functioning of the Golgi network and ensuring that vesicles are correctly trafficked to their destinations within the cell. Disruption of YIPF6 function can interfere with cellular logistics, impacting various essential processes such as protein secretion and membrane recycling.
Inhibitors of YIPF6 function by binding to the protein and preventing it from participating in its normal interactions with Rab GTPases and other molecules involved in vesicle trafficking. This inhibition can cause defects in the transport pathways that rely on YIPF6, potentially leading to mislocalization of proteins and lipids, disruption of Golgi structure, and impairments in vesicle formation and fusion. Since vesicular trafficking is a crucial aspect of cellular function, YIPF6 inhibition can have wide-ranging effects on cellular homeostasis, affecting processes like protein sorting, lipid metabolism, and membrane turnover. Understanding the structural interactions between YIPF6 and its inhibitors is vital for determining how these compounds modulate the protein's activity and how they impact the broader cellular trafficking networks that rely on YIPF6 function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Can inhibit mTOR signaling which has broad influences on protein synthesis and cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that may affect pathways indirectly linked with YIPF6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor potentially modulating pathways related to YIPF6. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad kinase inhibitor that can impact multiple cellular pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which can be involved in many signaling pathways, possibly affecting YIPF6. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can have an indirect influence on YIPF6 through related pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
P38 MAPK inhibitor; its modulation may indirectly relate to YIPF6 functions. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $204.00 $265.00 | 29 | |
Inhibits Akt, and can affect downstream targets or pathways associated with YIPF6. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-kB pathway inhibitor which might indirectly influence processes linked with YIPF6. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho-associated protein kinase inhibitor, possibly influencing YIPF6-related pathways. | ||||||